FMO5 and infection: When a CGD patient with absent NAPDH-oxidase activity suffers from uncontrollable infections or severe inflammatory complications and has a suitable donor, HCT may be the treatment of choice, especially in patients younger than 30 years old, but if the patient has no available matched donor, gene therapy, or HLA-haploidentical BMT/PBSCT should be considered.